Drug discovery
Drug discovery process
–
See how we can help you at each stage of the drug discovery process.
See how we can help you at each stage of the drug discovery process.
Target Identification and Validation
Lead Generation
Lead Optimisation
Candidate Selection
Clinical
Therapeutic areas
–
See where our science is driving breakthroughs in disease research.
See where our science is driving breakthroughs in disease research.
Neuroscience
Oncology
Immunology
Infectious Disease
Capabilities
–
Discover the expertise and resources powering our innovative research.
Discover the expertise and resources powering our innovative research.
In vivo Biology
In vitro Biology
Translational Medicine
Technology platforms
–
Learn about the platforms accelerating innovation in discovery.
Learn about the platforms accelerating innovation in discovery.
Mass Spectrometry
Spatial Biology
Microscopy
Preclinical Imaging
Modalities
–
Explore the innovative approaches shaping modern therapeutics.
Explore the innovative approaches shaping modern therapeutics.
Small Molecules
Large Molecules
New Modalities
Radiopharmaceuticals
Proprietary technology
–
Uncover unique innovations available only through our research.
Uncover unique innovations available only through our research.
Chemical Protein Stability Assay (CPSA)
Consultancy
–
Partner with our experts to advance your drug discovery project.
Partner with our experts to advance your drug discovery project.
R&D Consultancy
Collaborative R&D
Global challenges
Antimicrobial Resistance
Total-body PET
Mental Health
RNA Therapeutics
Impact
Funding
About
Working with us
Success stories
Board
Leadership
People
Careers
Resources
News
Events
Blogs
Reports
Recordings
Publications
Speak to us
Speak to us
Impact
Enabling access to essential technologies and skills
Driving better predictability of preclinical medicines discovery
Facilitating access to world-class industry skills in R&D
Leading the conversation for the drug discovery sector
Addressing unmet patient need
Connecting the UK Life Sciences ecosystem
Covid-19 pandemic response
Case studies
Area of Impact
Addressing unmet patient needs
Connecting the UK Life Sciences ecosystem
Driving better predictability of preclinical medicines discovery
Enabling access to essential technologies and skills
Facilitating access to world-class industry skills in R&D
Impact
Leading the conversation for the drug discovery sector
Fast forward to the future of biomolecule analysis
Biomarkers
Health Data
SMi
Virtual R&D
Read more
A lesson in Life Sciences
Community
UK Life Sciences
Read more
CF AMR Syndicate
CF AMR Syndicate
Syndicates
Read more
0
0
2
View more
